Chapter 3 Market and Technology Background
- Overview of Plasma Fractionation
- Classic Fractionation Methods (Cohn Fractionation)
- Components of Blood Plasma
- Functions of Blood Plasma
- Blood Donation
- Collection and Extraction of Blood Plasma
- Fractionation Methods for Extracting Individual Components of Plasma
- Government Funding of Blood Donation Facilities
- Government Regulations: FDA, International Regulatory Agencies and Medical Associations
- Clinical Guidelines
Chapter 4 Impact of COVID-19
- Introduction
- Outbreak
- Progression of COVID-19
- Government Expenditures on COVID-19
- Social Impact of COVID-19
- Impact on Insurance Providers
- Impact on Health Technology Assessment
Chapter 5 Market Dynamics
- Market Drivers
- Overview
- Growing Use of Immunoglobulins in Various Therapeutic Areas
- Growing Prevalence of Alpha-1 Antitrypsin Deficiency (AATD) and Respiratory Diseases
- Growing Geriatric Population
- Increase in Blood Donations
- Market Restraints
- High Costs Associated with Plasma Therapies
- Stringent Government Regulations and Low Reimbursement Policies
- Market Opportunities
- Opportunities in Emerging Nations
Chapter 6 Market Breakdown by Product
- Global Market for Plasma Fractionation by Product
- Immunoglobulins
- Albumins
- Coagulation Factor Concentrates
- Others
Chapter 7 Market Breakdown by Application
- Global Plasma Fractionation Market by Application
- Neurology
- Immunology
- Hematology
- Others
Chapter 8 Market Breakdown by End User
- Global Plasma Fractionation Market by End User
- Hospitals and Clinics
- Research Laboratories
- Others
Chapter 9 Market Breakdown by Region
- Global Market for Plasma Fractionation by Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Chapter 10 Competitive Landscape
- Global Company Ranking
- Porter's Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Competitive Rivalry/Degree of Competition
Chapter 11 Company Profiles
- ADMA Biologics Inc.
- Baxter
- China Biologic Products Inc.
- Csl Ltd.
- Grifols S.A.
- Kedrion Spa
- Octapharma Ag
List of Tables
Summary Table A: Global Market for Plasma Fractionation, by Product, Through 2025
Summary Table B: Global Market for Plasma Fractionation, by Application, Through 2025
Table 1: Blood Plasma Components
Table 2: Plasma Constituents and Their Function
Table 3: Percentage of Major Proteins Present in Different Fractions After Cohn’s Fractionation Method
Table 4: Expenditures on COVID-19 Crisis, by Country
Table 5: Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
Table 6: Use of Immunoglobulin in Hematology
Table 7: Use of Immunoglobulin in Neurology
Table 8: Use of Immunoglobulin in Infectious Diseases
Table 9: Use of Immunoglobulin in Neurology
Table 10: Number and Distribution of Persons Aged 60 and Over, by Region, 2017 and 2050
Table 11: Global Market for Plasma Fractionation, by Product, Through 2025
Table 12: Global Market for Plasma Fractionation of Immunoglobulins, by Region, Through 2025
Table 13: Albumin Products, by Company
Table 14: Global Market for Plasma Fractionation of Albumin, by Region, Through 2025
Table 15: Global Market for Plasma Fractionation of Coagulation Factor Concentrates, by Region, Through 2025
Table 16: Global Market for Plasma Fractionation of Other Products, by Region, Through 2025
Table 17: Global Market for Plasma Fractionation, by Application, Through 2025
Table 18: Global Market for Plasma Fractionation in Neurology, by Region, Through 2025
Table 19: Global Market for Plasma Fractionation in Immunology, by Region, Through 2025
Table 20: Global Market for Plasma Fractionation in Hematology, by Region, Through 2025
Table 21: Global Market for Plasma Fractionation of Other Applications, by Region, Through 2025
Table 22: Global Market for Plasma Fractionation, by End User, Through 2025
Table 23: Global Market for Plasma Fractionation in Hospital and Clinics, by Region, Through 2025
Table 24: Global Market for Plasma Fractionation in Research Laboratories, by Region, Through 2025
Table 25: Global Market for Plasma Fractionation Used by Other End Users, by Region, Through 2025
Table 26: Global Market for Plasma Fractionation, by Region, Through 2025
Table 27: North American Market for Plasma Fractionation, by Product, Through 2025
Table 28: North American Market for Plasma Fractionation, by Country, Through 2025
Table 29: European Market for Plasma Fractionation, by Product, Through 2025
Table 30: European Market for Plasma Fractionation, by Country/Region, Through 2025
Table 31: Asia-Pacific Market for Plasma Fractionation, by Product, Through 2025
Table 32: Asia-Pacific Market for Plasma Fractionation, by Country/Region, Through 2025
Table 33: Japanese Market Statistics
Table 34: Latin American Market for Plasma Fractionation, by Product, Through 2025
Table 35: Middle Eastern and African Market for Plasma Fractionation, by Product, Through 2025
Table 36: Global Company Ranking in the Market for Plasma Fractionation, 2019
Table 37: Porter's Five Forces Analysis
Table 38: ADMA Biologics Inc.: Products and Services
Table 39: ADMA Biologics Inc.: Recent Developments, 2017-2020
Table 40: Baxter: Products and Services
Table 41: China Biologic Products Holdings Inc.: Products and Services
Table 42: China Biologic Products Holdings Inc.: Pipeline Plasma Products
Table 43: China Biologic Products Holdings Inc.: Recent Developments, 2017
Table 44: CSL Ltd.: Products and Services
Table 45: CSL Ltd.: Recent Developments, 2017-2020
Table 46: Grifols, S.A.: Products and Services
Table 47: Grifols, S.A..: Recent Developments, 2017-2020
Table 48: Kedrion SpA: Products and Services
Table 49: Kedrion SpA: Recent Developments, 2017-2020
Table 50: Octapharma AG: Products and Services
Table 51: Octapharma AG: Recent Developments, 2020
List of Figures
Summary Figure A: Global Market Shares for Plasma Fractionation, by Product, 2019
Summary Figure B: Global Market Shares for Plasma Fractionation, by Application, 2019
Figure 1: Comparison of GDP Growth, by Countries, 2019 and 2020
Figure 2: FDA Regulation for Approval of Blood Products and Devices
Figure 3: Global Market Shares for Plasma Fractionation, by Product, 2019
Figure 4: Immunoglobulin Products
Figure 5: Categorization of Subcutaneous Immunoglobulin
Figure 6: Global Market for Plasma Fractionation of Immunoglobulins, 2018-2025
Figure 7: Global Market for Plasma Fractionation of Immunoglobulins, by Region, 2018-2025
Figure 8: Global Market for Plasma Fractionation of Albumin, 2018-2025
Figure 9: Global Market for Plasma Fractionation of Albumin, by Region, 2018-2025
Figure 10: Global Market for Plasma Fractionation of Coagulation Factor Concentrates, 2018-2025
Figure 11: Global Market for Plasma Fractionation of Coagulation Factor Concentrates, by Region, 2018-2025
Figure 12: Global Market for Plasma Fractionation of Other Products, 2018-2025
Figure 13: Global Market for Plasma Fractionation of Other Products, by Region, 2018-2025
Figure 14: Global Market Shares for Plasma Fractionation, by Application, 2019
Figure 15: Global Market for Plasma Fractionation in Neurology, 2018-2025
Figure 16: Global Market for Plasma Fractionation in Neurology, by Region, 2018-2025
Figure 17: Global Market for Plasma Fractionation in Immunology, 2018-2025
Figure 18: Global Market for Plasma Fractionation in Immunology, by Region, 2018-2025
Figure 19: Global Market for Plasma Fractionation in Hematology, 2018-2025
Figure 20: Global Market for Plasma Fractionation in Hematology, by Region, 2018-2025
Figure 21: Global Market for Plasma Fractionation of Other Applications, 2018-2025
Figure 22: Global Market for Plasma Fractionation of Other Applications, by Region, 2018-2025
Figure 23: Global Market Shares for Plasma Fractionation, by End User, 2019
Figure 24: Global Market for Plasma Fractionation in Hospital and Clinics, 2018-2025
Figure 25: Global Market for Plasma Fractionation in Hospital and Clinics, by Region, 2018-2025
Figure 26: Global Market for Plasma Fractionation in Research Laboratories, 2018-2025
Figure 27: Global Market for Plasma Fractionation in Research Laboratories, by Region, 2018-2025
Figure 28: Role of Platelet-Rich Plasma in Treatment
Figure 29: Global Market for Plasma Fractionation Used by Other End Users, 2018-2025
Figure 30: Global Market for Plasma Fractionation Used by Other End Users, by Region, 2018-2025
Figure 31: Global Market for Plasma Fractionation, by Region, 2018-2025
Figure 32: Global Market Shares for Plasma Fractionation, by Region, 2019
Figure 33: North American Market Shares for Plasma Fractionation, by Product, 2019
Figure 34: North American Market Shares for Plasma Fractionation, by Country, 2019
Figure 35: U.S. Market for Plasma Fractionation, 2019-2025
Figure 36: Canadian Market for Plasma Fractionation, 2019-2025
Figure 37: European Market Shares for Plasma Fractionation, by Product, 2019
Figure 38: European Market Shares for Plasma Fractionation, by Country/Region, 2019
Figure 39: German Market for Plasma Fractionation, 2019-2025
Figure 40: French Market for Plasma Fractionation, 2019-2025
Figure 41: U.K. Market for Plasma Fractionation, 2019-2025
Figure 42: Italian Market for Plasma Fractionation, 2019-2025
Figure 43: Spanish Market for Plasma Fractionation, 2019-2025
Figure 44: Rest of European Market for Plasma Fractionation, 2019-2025
Figure 45: Asia-Pacific Market Shares for Plasma Fractionation, by Product, 2019
Figure 46: Asia-Pacific Market Shares for Plasma Fractionation, by Country/Region, 2019
Figure 47: Chinese Market for Plasma Fractionation, 2019-2025
Figure 48: Japanese Market for Plasma Fractionation, 2019-2025
Figure 49: Indian Market for Plasma Fractionation, 2019-2025
Figure 50: Australian Market for Plasma Fractionation, 2019-2025
Figure 51: South Korean Market for Plasma Fractionation, 2019-2025
Figure 52: Rest of Asia-Pacific Market for Plasma Fractionation, 2019-2025
Figure 53: Latin American Market for Plasma Fractionation, 2019-2025
Figure 54: Latin American Market Shares for Plasma Fractionation, by Product, 2019
Figure 55: Middle Eastern and African Market for Plasma Fractionation, 2019-2025
Figure 56: Middle Eastern and African Market Shares for Plasma Fractionation, by Product, 2019
Figure 57: ADMA Biologics Inc.: Financials, 2015-2019
Figure 58: ADMA Biologics Inc.: Revenue Share, by Business Segment, 2019
Figure 59: Baxter: Annual Revenue, 2015-2019
Figure 60: Baxter: Revenue Share, by Business Unit, 2019
Figure 61: Baxter: Revenue Share, by Region, 2019
Figure 62: China Biologic Products Holdings Inc.: Financials, 2015-2019
Figure 63: China Biologic Products Holdings Inc.: Revenue Share, by Segment, 2019
Figure 64: CSL Ltd.: Financials, 2015-2019
Figure 65: CSL Ltd.: Revenue Share, by Segment, 2019
Figure 66: CSL Ltd.: Revenue Share, by Country/Region, 2019
Figure 67: Grifols S.A.: Financials, 2015-2019
Figure 68: Grifols S.A.: Revenues Share, by Segment, 2019
Figure 69: Grifols S.A.: Revenue Share, by Country/Region, 2019
Figure 70: Kedrion SpA: Financials, 2015-2019
Figure 71: Kedrion SpA: Revenue Share, by Segment, 2019
Figure 72: Kedrion SpA: Revenue Share, by Country/Region, 2019
Figure 73: Octapharma AG: Financials, 2015-2019
Figure 74: Octapharma AG: Revenue, by Operating Income, 2015-2019
